Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-77.48%
operating margin TTM
-76.91%
revenue TTM
333.87 Million
revenue per share TTM
0.99$
valuation ratios | |
|---|---|
| pe ratio | -1.72 |
| peg ratio | -0.07 |
| price to book ratio | 5.57 |
| price to sales ratio | 1.75 |
| enterprise value multiple | -2.78 |
| price fair value | 5.57 |
profitability ratios | |
|---|---|
| gross profit margin | 97.4% |
| operating profit margin | -76.91% |
| pretax profit margin | -77.72% |
| net profit margin | -77.48% |
| return on assets | -64.89% |
| return on equity | -293.05% |
| return on capital employed | -125.94% |
liquidity ratios | |
|---|---|
| current ratio | 1.05 |
| quick ratio | 1.05 |
| cash ratio | 0.80 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 22.23 |
| days of payables outstanding | 919.78 |
| cash conversion cycle | -897.55 |
| receivables turnover | 16.42 |
| payables turnover | 0.40 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.24 |
| debt equity ratio | 1.20 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.54 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -1.53 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.14 |
| cash per share | 0.15 |
| operating cash flow per share | -0.14 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -1.53 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -123.36 |
Frequently Asked Questions
When was the last time Sangamo Therapeutics, Inc. (NASDAQ:SGMO) reported earnings?
Sangamo Therapeutics, Inc. (SGMO) published its most recent earnings results on 06-11-2025.
What is Sangamo Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Sangamo Therapeutics, Inc. (NASDAQ:SGMO)'s trailing twelve months ROE is -293.05%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Sangamo Therapeutics, Inc. (SGMO) currently has a ROA of -64.89%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SGMO's net profit margin stand at?
SGMO reported a profit margin of -77.48% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SGMO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.05 in the most recent quarter. The quick ratio stood at 1.05, with a Debt/Eq ratio of 1.20.